Comparative Pharmacology
Head-to-head clinical analysis: GLYCOLAX versus PEG LYTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GLYCOLAX versus PEG LYTE.
GLYCOLAX vs PEG-LYTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative. Polyethylene glycol (PEG) increases intraluminal water volume in the colon by osmosis, promoting stool passage and relieving constipation.
PEG-LYTE is an osmotic laxative that induces diarrhea by retaining water in the colon through the non-absorbable polyethylene glycol (PEG) and electrolytes, which prevent dehydration and electrolyte imbalance during bowel cleansing.
17 g (1 heaping tablespoon) dissolved in 4-8 ounces of liquid once daily, orally.
4 liters orally as a single dose or in divided doses for colonoscopy preparation.
None Documented
None Documented
Not applicable due to negligible systemic absorption; local colonic transit time approximately 2-4 hours.
Not applicable; PEG-3350 is minimally absorbed (<0.06%), thus systemic half-life is not clinically relevant. Local gut transit time ~1-2 hours.
Minimally absorbed; excreted primarily unchanged in feces via osmotic action. Renal excretion negligible (<0.2% absorbed dose).
Primarily fecal (98-99%) as unchanged polyethylene glycol (PEG) 3350; negligible renal excretion (<0.2%). Electrolytes (sodium, potassium, bicarbonate) are partially absorbed and excreted renally.
Category C
Category C
Osmotic Laxative
Osmotic Laxative